Literature DB >> 21555772

Penetration of intact blood-brain barrier by doripenem.

K Margetis, E Dimaraki, G Charkoftaki, E Vryonis, S Markantonis, N Boutos, H Archontaki, D E Sakas, G Valsami, A Skoutelis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21555772      PMCID： PMC3122383          DOI： 10.1128/AAC.01634-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  12 in total

1.  Study of the synergism between carbapenems and vancomycin or teicoplanin against MRSA, focusing on S-4661, a carbapenem newly developed in Japan.

Authors:  Yoshio Kobayashi
Journal:  J Infect Chemother       Date:  2005-10       Impact factor: 2.211

2.  Biofilm formation in Acinetobacter baumannii: associated features and clinical implications.

Authors:  J Rodríguez-Baño; S Martí; S Soto; F Fernández-Cuenca; J M Cisneros; J Pachón; A Pascual; L Martínez-Martínez; C McQueary; L A Actis; J Vila
Journal:  Clin Microbiol Infect       Date:  2008-01-10       Impact factor: 8.067

3.  Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).

Authors:  T R Fritsche; M G Stilwell; R N Jones
Journal:  Clin Microbiol Infect       Date:  2005-12       Impact factor: 8.067

4.  Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.

Authors:  Ronald N Jones; Helio S Sader; Thomas R Fritsche
Journal:  Diagn Microbiol Infect Dis       Date:  2005-05       Impact factor: 2.803

5.  In vivo pharmacodynamic profiling of doripenem against Pseudomonas aeruginosa by simulating human exposures.

Authors:  Aryun Kim; Mary Anne Banevicius; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

6.  Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics.

Authors:  Masahito Horiuchi; Megumi Kimura; Miwa Tokumura; Nobuyoshi Hasebe; Tohko Arai; Kohji Abe
Journal:  Toxicology       Date:  2006-03-06       Impact factor: 4.221

Review 7.  Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.

Authors:  S James Matthews; Jason W Lancaster
Journal:  Clin Ther       Date:  2009-01       Impact factor: 3.393

8.  Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp.

Authors:  Mariana Castanheira; Ronald N Jones; David M Livermore
Journal:  Diagn Microbiol Infect Dis       Date:  2009-02-26       Impact factor: 2.803

9.  Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases.

Authors:  Shazad Mushtaq; Yigong Ge; David M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

10.  A retrospective study of central nervous system shunt infections diagnosed in a university hospital during a 4-year period.

Authors:  Suzan Sacar; Huseyin Turgut; Semra Toprak; Bayram Cirak; Erdal Coskun; Ozlem Yilmaz; Koray Tekin
Journal:  BMC Infect Dis       Date:  2006-03-08       Impact factor: 3.090
View more
  1 in total

Review 1.  Cerebral microdialysis in clinical studies of drugs: pharmacokinetic applications.

Authors:  Richard J Shannon; Keri L H Carpenter; Mathew R Guilfoyle; Adel Helmy; Peter J Hutchinson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-03-07       Impact factor: 2.745
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.